Imagine that your tear production is reasonable. Your meibomian glands are functioning reasonably well. You apply artificial tears. And yet one part of the cornea repeatedly becomes dry and irritated.
There is another question worth asking:
What if your eye is dry because it is not properly protected?
Imagine that your tear production is reasonable. Your meibomian glands are functioning reasonably well. You apply artificial tears. And yet one part of the cornea repeatedly becomes dry and irritated.
There is another question worth asking:
Your eyelids are not simply curtains that open when you wake up and close when you sleep. They are part of the tear-film system. Every complete blink spreads tears across the ocular surface. And when the eyes close during sleep, the lids physically protect the cornea from the surrounding environment.
If that protection is incomplete, the ocular surface may remain exposed for hours. That creates a very different kind of dry-eye problem.
Exposure keratopathy refers to damage to the corneal surface caused by inadequate protection from the eyelids. Normally, the eyelids create a closed environment over the eye. If part of the cornea remains exposed, that area can experience:
In more significant cases, exposure can lead to epithelial defects and more serious corneal complications. So this is not simply “my eye feels a little dry.” The eyelids are an important physical barrier protecting living tissue.
Lagophthalmos means that the eyelids cannot close completely. It can occur for many reasons, including:
But there is also a particularly easy-to-miss form: nocturnal lagophthalmos. That means the eyes do not close completely during sleep.
That is exactly the problem. You are asleep. Someone can have incomplete eyelid closure for hours every night and have no idea it is happening. A partner may notice it. Sometimes it can be identified during an eye examination or by carefully assessing lid closure. And sometimes the symptom pattern provides the first clue. For example:
These symptoms do not prove nocturnal exposure. But they make the question worth asking.
Nocturnal lagophthalmos is a recognized contributor to dry-eye symptoms, and research has found an association between nocturnal lagophthalmos and dry-eye disease.
Probably more common than many people realize. A 2025 report discussing nocturnal lagophthalmos cited estimates that incomplete eyelid closure during sleep occurs in roughly 5% of the population. But prevalence estimates should be interpreted cautiously because detecting something that happens during sleep is inherently difficult.
The important point is simply that nocturnal lagophthalmos is not an exotic condition. And it can easily remain unnoticed.
During the day, blinking repeatedly redistributes the tear film. You may also use artificial tears, moisture chambers or other treatments. During sleep, none of that is happening. If the lids close normally, this is usually fine because the ocular surface is physically protected.
But imagine one small area remains exposed for six, seven or eight hours. There is no normal blinking. There is no conscious application of drops. And the same area may remain vulnerable for much of the night.
That is why exposure-related disease can sometimes produce a distinctive pattern:
worse on wakingimproves after the eye has been open and blinking for a while
Again, that pattern is a clue, not a diagnosis.
Yes. The eyelids do not need to be dramatically open. A relatively small gap may expose a portion of the ocular surface. And if the same area remains exposed repeatedly, night after night, it can become clinically relevant.
This is one reason asking “Do I sleep with my eyes open?” can be misleading. The answer does not have to be “Yes, your eyes are obviously open.” The relevant question is:
Not exactly. They are related because both involve inadequate lid coverage. But they occur in different circumstances.
Incomplete blinking happens while you are awake. The upper eyelid begins a blink but does not travel far enough to meet the lower lid. That can leave part of the ocular surface repeatedly insufficiently refreshed. Lagophthalmos refers to incomplete eyelid closure. And nocturnal lagophthalmos specifically occurs during sleep.
A person can have one without the other. Or both.
TFOS DEWS III recognizes blink and lid-closure abnormalities as an etiological category that should be specifically evaluated when subclassifying dry eye.
Not necessarily. This distinction is important. Imagine pouring water onto a surface while continuously blowing dry air across part of it. Adding more water may help. But it does not remove the exposure.
Similarly, a person can have adequate tear production and still experience local desiccation if part of the ocular surface remains insufficiently protected. So a dry ocular surface does not always mean insufficient tear production. Sometimes the problem is insufficient coverage.
Absolutely. And this is where real dry eye becomes much messier than textbook categories. Suppose someone has a weak lipid layer plus incomplete eyelid closure. Now the exposed surface is losing water through evaporation while the tear film is already poorly protected against evaporation. Those two problems can amplify each other.
The same is true for aqueous deficiency. A patient with very little tear volume may tolerate even a small amount of exposure poorly. So exposure can be the main driver or an additional stressor on an already compromised tear film.
The basic treatment principle is beautifully simple: protect the ocular surface while you sleep. How that is achieved depends on the severity and cause of the exposure. Options may include:
These approaches do not all do the same thing.
Ointments are much thicker than ordinary artificial tears. That makes them inconvenient during the day because they blur vision. At night, blurred vision obviously matters much less. Their thickness allows them to remain on the ocular surface longer and provide prolonged lubrication.
So if exposure is mild, an ointment may provide enough protection to reduce overnight desiccation. But notice what the ointment does: it protects the exposed surface. It does not necessarily correct the lid closure itself.
A moisture chamber reduces air exchange around the eye and creates a humid microenvironment. We discussed this in the previous article. But with nocturnal exposure, the concept becomes even more intuitive. If the eyelid does not completely isolate the cornea from the environment, another barrier can be placed outside the eye.
Older clinical work with humidity chambers in patients with lagophthalmos demonstrated that enclosed chambers can maintain extremely high local humidity for many hours. So instead of trying to compensate for exposure only with more lubricant, we can also change the environment around the exposed surface.
For selected patients, taping can physically help keep the eyelids closed during sleep. This directly addresses the mechanical problem. But it needs to be done carefully. The goal is not simply to stick some tape somewhere around the eye. Poor technique can irritate the eyelid skin or fail to produce proper closure. And someone with persistent or significant lagophthalmos should have the cause evaluated rather than indefinitely improvising at home.
Published clinical literature describes overnight lid taping and moisture chambers as protective options when lubrication alone is insufficient for exposure.
Because they are treating completely different problems. Suppose the problem is that the eyelid remains partly open all night. A sophisticated artificial tear may improve lubrication. An anti-inflammatory medication may reduce inflammation. A lipid drop may temporarily supplement the tear film. But none of those treatments physically closes the gap. Taping may.
This is one of the clearest examples of the central principle of this entire Guide: the treatment has to match the mechanism.
No. A more protected nighttime environment may help for several reasons. For example, taping may reduce exposure even in someone whose closure is not dramatically abnormal. So improvement is useful information, but it should not replace an examination.
Again: response to treatment can provide a clue. It is not automatically a diagnosis.
That can be another clue worth investigating. Asymmetric symptoms may occur for many reasons. But if one eye consistently feels worse overnight, is redder in the morning or shows more inferior corneal staining, it is reasonable to examine whether eyelid closure or anatomy differs between the two sides.
Even sleeping position may interact with ocular-surface exposure and the local environment. But asymmetry alone does not establish the cause.
Then exposure may not be the explanation. Nighttime or morning symptoms can also occur with:
That is why “my eyes are dry in the morning” should not automatically become “I sleep with my eyes open.” It is a diagnostic clue that needs context.
Yes. Any procedure that changes eyelid position or the amount of skin available for closure can potentially affect how completely the lids meet. This does not mean eyelid surgery inevitably causes dry eye. But postoperative lid position and closure are important when symptoms appear after procedures involving the eyelids or surrounding tissues.
The same principle applies to structural changes from scarring, trauma or certain orbital diseases.
Thyroid eye disease can cause the eyes to become more prominent and alter eyelid position. That can increase ocular exposure. In this situation, simply treating the resulting dryness with artificial tears may provide symptomatic support, but the broader orbital and eyelid problem also matters.
Again: surface treatment and treatment of the underlying driver are not always the same thing.
The facial nerve controls muscles involved in eyelid closure. If facial nerve function is impaired, complete closure may become difficult or impossible. This can create significant exposure keratopathy.
In these cases, management may range from intensive lubrication and moisture protection to procedures designed to improve eyelid closure. The more severe the exposure, the more important it becomes to protect the cornea rather than treating the problem as ordinary dry eye.
Mild exposure may cause irritation and punctate epithelial staining. More severe or prolonged exposure can produce:
So significant inability to close the eye is not something to manage indefinitely with random over-the-counter drops. The cornea needs protection.
Yes. This connects directly with the article on scleral lenses. A therapeutic scleral lens can create a fluid reservoir over the cornea and physically protect it from the external environment. For selected patients with significant exposure-related ocular-surface disease, this can be extremely useful.
Again, however, the scleral lens protects the cornea. It does not necessarily restore normal eyelid closure.
Then the eyelid problem itself may need to be treated. Depending on the cause, ophthalmic or oculoplastic management may include procedures that:
In severe cases, procedures such as tarsorrhaphy can partially close the eyelids to protect the cornea. The appropriate treatment depends entirely on why closure is impaired. This is well beyond simply choosing another dry-eye drop.
Again, measure the thing you are trying to change. Useful outcomes might include:
But if significant exposure remains visible despite symptom improvement, the cornea still needs appropriate monitoring. Symptoms alone do not tell us everything about surface damage.
Wolffsohn JS, et al. TFOS DEWS III: Diagnostic Methodology.
The updated framework specifically separates eyelid abnormalities, including blink and lid closure, as etiological components of dry-eye disease.
Jones L, et al. TFOS DEWS III: Management and Therapy.
Current evidence-based framework emphasizing treatment targeted to the individual etiological drivers of dry eye rather than a one-treatment-fits-all approach.
Nocturnal Lagophthalmos and Sleep Quality in Patients with Dry Eye Disease.
Study examining the relationship between nocturnal lagophthalmos, dry-eye disease and sleep-related factors.
Kandzia C, Duncker G. New Permanent Humidity Chamber in Dry Eye Disorders.
Clinical work demonstrating prolonged high humidity around eyes affected by eyelid-closure disorders using an enclosed moisture chamber.